Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 黑料网 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
黑料网 Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Immunotherapy and Biomarker for Efficacy in Lymphoma
Immune Checkpoint Inhibitor (ICI), especially programmed cell-death protein 1 ligand 1 (PD-L1)/PD-L2 and the programmed cell-death protein 1 (PD-1) axis inhibitor, has become an essential part of treatment for patients with solid tumors, including melanoma, lung cancer and gastric cancer. As for hematological malignancies, ICI has also been introdu... Read More»
Hirotaka Nakamura and Nobuhiko Yamauchi
: Diagn Pathol Open 6: 179
10.4172/2476-2024.1000179Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article
Make the best use of Scientific Research and information from our 700 + peer reviewed, 黑料网 Journals